Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Engages Auditors for 2008 Through 2011 SEC Reporting
6/28/2011 8:02:40 AM
More...
|
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Submits FDA Application for 'Fast Track' Status for CVBT-141B, CVBT's Biological Treatment for Diabetes Patients
2/3/2011 9:58:48 AM
More...
|
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Announces Diabetic Wounds Drug Phase II Clinical Trial Data
1/4/2011 6:41:39 AM
More...
|
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Licenses Phase II Diabetic Wound Healing Data From Cardiovascular BioTherapeutics, Inc. (CVBT.OB)
11/30/2010 9:00:16 AM
More...
|
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Opens Florida and Arizona Sites for Its ACORD Phase II Heart Trial
2/24/2009 10:56:20 AM
More...
|
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Opens Two Additional Sites for Its ACORD Phase II Heart Trial
1/8/2009 9:09:51 AM
More...
|
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial
12/11/2008 8:13:45 AM
More...
|
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease
11/25/2008 9:45:30 AM
More...
|
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate
11/13/2008 7:14:26 AM
More...
|
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial
9/9/2008 9:04:18 AM
More...
|
|